Imaging Diagnostic Systems' hopes of joining the mammography sweepstakes are pinned on its computed tomography laser mammography (CTLM) system gaining FDA premarket approval next year.IDS in Plantation, FL, has been developing its system for several
Imaging Diagnostic Systems' hopes of joining the mammography sweepstakes are pinned on its computed tomography laser mammography (CTLM) system gaining FDA premarket approval next year.
IDS in Plantation, FL, has been developing its system for several years. It hopes to complete the PMA process early in 2001. Another company, Advanced Research and Technology (ART) of Montreal, is working on a similar system, called SoftScan.
Both SoftScan and IDS's CTLM system train the laser energy on one side of the breast and place a detector on the other side to catch the photons after they pass through the tissue.
The ART system uses a stationary light source to create 2-D images, whereas CTLM's lasers rotate around the breast to create 3-D tomographic images. ART likewise hopes to clear the FDA in 2001 and begin marketing its product in 2002.
Both systems are considered adjuncts to x-ray mammography. n
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.